Agios Pharmaceuticals (AGIO) Other Working Capital Changes (2012 - 2026)

Agios Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$4.5 million for Q1 2026.

• Quarterly Other Working Capital Changes fell 10.23% year-over-year to -$4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.2 million (down 11.61% YoY) and the FY2025 annual result came in at -$16.8 million, down 11.81% from the prior year.
• Other Working Capital Changes was -$4.5 million for Q1 2026 at Agios Pharmaceuticals, down from -$4.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $5.3 million in Q3 2024 and bottomed at -$7.5 million in Q4 2022.
• A 5-year average of $457764.7 and a median of $948000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 2424.2% in 2024, while the deepest fall reached 328.56% in 2024.
• Agios Pharmaceuticals' Other Working Capital Changes stood at -$3.2 million in 2022, then retreated by 10.06% to -$3.5 million in 2023, then sank by 328.56% to -$15.0 million in 2024, then surged by 71.3% to -$4.3 million in 2025, then decreased by 3.57% to -$4.5 million in 2026.
• Business Quant data shows AGIO's Other Working Capital Changes at -$4.5 million in Q1 2026, -$4.3 million in Q4 2025, and -$11.7 million in Q3 2025.